Press release
Altimmune, Inc. (NASDAQ: ALT) Investor Alert: Deadline in Lawsuit on October 6, 2025
A Deadline is coming up on October 6, 2025 in the lawsuit for certain investors in Altimmune, Inc. (NASDAQ: ALT).
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and there are strict and short deadlines running. Deadline: October 6, 2025. NASDAQ: ALT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the District of Maryland the plaintiff alleges on behalf of purchasers of Altimmune, Inc. (NASDAQ: ALT) common shares between August 10, 2023 and June 25, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 10, 2023 and June 25, 2025, the The Altimmune class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to the results of Altimmune's IMPACT Phase 2b metabolic associated steatohepatitis ("MASH") trial; (ii) Altimmune failed to meet an important statistical significance marker relating to the fibrosis reduction primary endpoint; and (iii) Altimmune concealed higher responses in the placebo group, which defendants knew or should have known would negatively impact the IMPACT Phase 2b MASH trial's topline results.
The Altimmune class action lawsuit further alleges that on June 26, 2025, Altimmune announced topline results from the IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH and disclosed that "[a]lthough we saw positive trends in fibrosis improvement, statistical significant was not achieved on this endpoint." On this news, the price of Altimmune stock fell more than 53%, according to the complaint.
Those who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Altimmune, Inc. (NASDAQ: ALT) Investor Alert: Deadline in Lawsuit on October 6, 2025 here
News-ID: 4187190 • Views: …
More Releases from Shareholders Foundation, Inc.
Investigation announced for Investors in shares of iRobot Corporation (NASDAQ: I …
An investigation was announced for current long-term investors in shares of iRobot Corporation (NASDAQ: IRBT) concerning potential breaches of fiduciary duties by certain directors of iRobot Corporation.
Investors who are current long term investors in iRobot Corporation (NASDAQ: IRBT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: IRBT…
Investigation announced for Long-Term Investors in shares of Neogen Corporation …
An investigation was announced for long-term investors in shares of Neogen Corporation (NASDAQ: NEOG) concerning potential breaches of fiduciary duties by certain directors of Neogen Corporation.
Investors who are current long term investors in Neogen Corporation (NASDAQ: NEOG) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: NEOG stocks…
Lawsuit filed for Investors who lost money with shares of Fly-E Group, Inc. (NAS …
An investor, who purchased shares of Fly-E Group, Inc. (NASDAQ: FLYE), filed a lawsuit over alleged violations of Federal Securities Laws by Fly-E Group, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fly-E Group, Inc. (NASDAQ: FLYE) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: FLYE investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Investors who hold shares of Centene Corporation (NY …
An investigation was announced for current long-term investors in shares of Centene Corporation (NYSE: CNC) concerning potential breaches of fiduciary duties by certain directors of Centene Corporation.
Investors who are current long term investors in Centene Corporation (NYSE: CNC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: CNC…
More Releases for Altimmune
Lawsuit filed for Investors who lost money with shares of Altimmune, Inc. (NASDA …
An investor, who purchased shares of Altimmune, Inc. (NASDAQ: ALT), filed a lawsuit over alleged violations of Federal Securities Laws by Altimmune, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and for certain investors are short and strict deadlines running. Deadline: October 6, 2025. NASDAQ: ALT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Nasal Vaccines Market Top Companies Study - Vaxart, Inc, FluGen Inc, Altimmune, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nasal Vaccines Market - Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines), By Application (Influenza, COVID-19), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The Global Nasal Vaccines Market is estimated to reach over USD 935.2 Mn by 2034, exhibiting a CAGR of 8.6% during the forecast period.
Get Free Access…
Biodefense Market Future Business Opportunities 2025-2032 | XOMA corporation, Al …
Latest Report, titled "Biodefense Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Biodefense market has been expanding significantly in recent…
Deadline on July 5th coming up in Lawsuit for Investors in Altimmune, Inc. (NASD …
A deadline is coming up on July 5, 2024 in the lawsuit filed for certain investors of Altimmune, Inc. (NASDAQ: ALT) over alleged securities laws violations by Altimmune, Inc.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and there are strict and short deadlines running. Deadline: July 5, 2024. NASDAQ: ALT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…
Lawsuit filed for Investors who lost money with shares of Altimmune, Inc. (NASDA …
An investor, who purchased shares of Altimmune, Inc. (NASDAQ: ALT), filed a lawsuit over alleged violations of Federal Securities Laws by Altimmune, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and for certain investors are short and strict deadlines running. Deadline: July 5, 2024. NASDAQ: ALT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investigation announced for Investors in shares of Altimmune, Inc. (NASDAQ: ALT) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Altimmune, Inc.
Investors who purchased shares of Altimmune, Inc. (NASDAQ: ALT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Altimmune, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Gaithersburg, MD based Altimmune,…
